Alkermes Issues Press Release Highlighting Publication Of Previously-Disclosed Phase 3 Data For ALKS 5461 For Adjunctive Treatment of Major Depressive Disorder; BZ NOTE: Advisory Committee Panel Meeting For ALKS 5461 Is Scheduled Thurs., Nov. 1, 2018